Mitchell Lawrence Jones - 05 Sep 2023 Form 3 Insider Report for PALISADE BIO, INC. (PALI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PALI	Common Stock Purchase Option							05 Sep 2023	Common Stock	75,000	$0.6897	Direct	F1
holding	PALI	Restricted Stock Units							05 Sep 2023	Common Stock	54,700	$0.000000	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents an inducement stock option grant issued from the Palisade Bio 2021 Inducement Plan. The options vest quarterly in twelve (12) equal installments over a three (3) year period.
F2	Represents an inducement restricted stock unit grant issued from the Palisade Bio 2021 Inducement Plan. The RSUs vest as follows: (i) 4,556 shares vest on 11/6/2023 and (ii) the remaining 51,144 shares vest in equal installments over the following eleven (11) quarterly periods thereafter.
F3	Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4	N/A.